2004
DOI: 10.1124/jpet.103.061416
|View full text |Cite
|
Sign up to set email alerts
|

Effects of a Novel Cardioselective ATP-Sensitive Potassium Channel Antagonist, 1-[[5-[2-(5-Chloro-o-anisamido)ethyl]-β-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, Sodium Salt (HMR 1402), on Susceptibility to Ventricular Fibrillation Induced by Myocardial Ischemia: In Vitro and in Vivo Studies

Abstract: In the present study, a novel sulfonylthiourea, 1-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2004
2004
2023
2023

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 20 publications
(6 citation statements)
references
References 29 publications
0
6
0
Order By: Relevance
“…In fact, K ATP channel inhibition has been shown to prevent VF after acute myocardial infarction in non-insulin-dependent diabetic patients 33 . Furthermore, K ATP channel inhibition effectively prevented arrhythmias induced by the combination of acute myocardial ischemia and exercise in dogs with healed myocardial infarctions 9,10,34 . Notably, the antiarrhythmic effect was observed with compounds (HMR1883 and congeners) that were designed to selectively inhibit the heart sarcolemmal K ATP channel without affecting pancreatic insulin release or mitochondrial K ATP channels 35 .…”
Section: Discussionmentioning
confidence: 93%
“…In fact, K ATP channel inhibition has been shown to prevent VF after acute myocardial infarction in non-insulin-dependent diabetic patients 33 . Furthermore, K ATP channel inhibition effectively prevented arrhythmias induced by the combination of acute myocardial ischemia and exercise in dogs with healed myocardial infarctions 9,10,34 . Notably, the antiarrhythmic effect was observed with compounds (HMR1883 and congeners) that were designed to selectively inhibit the heart sarcolemmal K ATP channel without affecting pancreatic insulin release or mitochondrial K ATP channels 35 .…”
Section: Discussionmentioning
confidence: 93%
“…The contradictory involvement of mPTP in CB13-treated NRAM but not CB13-treated NRVM is possibly explained by functional differences of ion complexes within the inner membrane that are involved in ΔΨ m . For example, blocking the inner membrane ion channel, IMAC, was protective against arrhythmias by preventing ΔΨ m reduction, improving left ventricular developed pressure, and preventing action potential shortening ( Billman et al, 1998 ; Aon et al, 2003 ; Brown et al, 2008 ). As noted above, we recently reported that CB13 treatment prevents atrial refractoriness shortening in an ex vivo rat model exposed to atrial tachypacing, suggesting prevention of action potential shortening by CB13 ( Lee et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Predisposition of the heart to such electrical dysfunction and generation of fatal arrhythmias is high under conditions referred to as metabolic sinks [ 110 ] with compromised energetic status due to hypoxia or ischemia. While these conditions and sarcKATP channel openers predispose the heart to arrhythmogenesis [ 106 , 107 ], the blockers of sarcKATP channels increase ERP [ 111 ] and prevent the occurrence of ventricular arrhythmias [ 112 , 113 , 114 , 115 ]. On the other hand, the opening of sarcKATP channels can be vital to cellular survival in the face of these conditions and in fact, the pharmacological blockade of sarcKATP channels was shown to increase cell death in hearts exposed to ischemia/reperfusion [ 116 , 117 ].…”
Section: Potential Mechanisms Of Oxidative Stress Induced Ventricumentioning
confidence: 99%